AGMB AgomAb Therapeutics NV

NASDAQ
$13.25

AgomAb Therapeutics NV (AGMB) SEC Filings

Everything AGMB has filed with the SEC, newest first. An 8-K shows what it was about where we have classified it — an earnings release and a change of chief executive are both 8-Ks, and the form number alone doesn't separate them.

No SEC filings on record for AGMB.